Open Access

[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway

  • Authors:
    • Shuping You
    • Weihong Li
    • Yun Guan
  • View Affiliations

  • Published online on: February 19, 2024     https://doi.org/10.3892/mmr.2024.13184
  • Article Number: 60
  • Copyright : © You et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Mol Med Rep 17: [Related article:] 4203–4212, 2018; DOI: 10.3892/mmr.2018.8444

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Fig. 1B and C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

April-2024
Volume 29 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
You S, Li W and Guan Y: [Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway. Mol Med Rep 29: 60, 2024
APA
You, S., Li, W., & Guan, Y. (2024). [Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway. Molecular Medicine Reports, 29, 60. https://doi.org/10.3892/mmr.2024.13184
MLA
You, S., Li, W., Guan, Y."[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway". Molecular Medicine Reports 29.4 (2024): 60.
Chicago
You, S., Li, W., Guan, Y."[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway". Molecular Medicine Reports 29, no. 4 (2024): 60. https://doi.org/10.3892/mmr.2024.13184